Brain Injury Terminated Phase 2 Trials for Erythropoietin (DB00016)

Also known as: Brain Injuries / Brain Damage / Head injury NOS / Cerebral damage / Brain injury NOS

IndicationStatusPhase
DBCOND0028243 (Brain Injury)Terminated2
clinicaltrials.gov IdentifierTitlePurposeDrugs
NCT00589953High-Dose Erythropoietin in Extremely Premature Infants to Prevent/Attenuate Brain Injury: A Phase II StudyPrevention